SCHEDULE OF ADJUSTMENT INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Total Revenue	$ 19,798,822	$ 16,238,200
Cost of Sales	11,301,814	12,085,574
General and Administrative	23,491,130	6,337,364
Total Operation Expenses	34,792,944	18,422,938
Loss From Continuing Operations	(14,994,122)	(2,184,738)
Interest Expense	(317,281)	(147,640)
Foreign Exchange Transaction Loss	1,363,061	(371,603)
Unrealized Gain (Loss) on Securities Investment	(49,190,748)	(1,694,535)
Finance Costs	(50,871,869)	(109,916)
Other Income	93,823	127,100
Total Other Expense, Net	(103,489,455)	(2,489,599)
Net Loss from Continuing Operations Before Income Taxes	(118,483,577)	(4,674,337)
Income Tax Expense from Continuing Operations	534,014	8,543
Net Loss from Continuing Operations	(119,017,591)	(4,682,880)
Loss from Discontinued Operations, Net of Tax		(417,438)
Net Loss	(119,017,591)	(5,100,318)
Net Loss Attributable to Non-Controlling Interest	(15,694,415)	(1,948,661)
Net Loss Attributable to Common Stockholders	(103,323,176)	(3,151,657)
Unrealized Gain on Securities Investment	(57,179)	19,486
Foreign Currency Translation Adjustment	3,974,966	(1,148,898)
Comprehensive Loss	(123,049,736)	(3,931,934)
Comprehensive Loss Attributable to Non-Controlling Interests	(16,933,170)	(1,381,863)
Comprehensive Loss Attributable to Common Stockholders	$ (106,116,566)	$ (2,550,071)
Continuing Operations	$ (3.69)	$ (0.33)
Discontinued Operations		(0.05)
Net Loss Per Common Share	$ (3.69)	$ (0.38)
Weighted Average Common Shares Outstanding - Basic and Diluted	27,982,876	8,352,425
Cash	$ 56,061,309	$ 24,965,946
Restricted Cash	4,740,870	6,769,533
Account Receivables, Net	39,622	1,366,194
Other Receivables	334,788	644,576
Note Receivables - Related Party	12,792,671	649,569
Prepaid Expenses	1,202,451	1,470,680
Inventory	47,290	90,068
Investment in Securities at Fair Value	36,337,023	49,172,457
Investment in Securities at Cost	99,216	280,516
Deposits	275,204	48,820
Total Current Assets	142,731,573	85,458,359
Operating Lease Right-Of-Use Asset	659,620	574,754
Deposit	39,653	249,676
Property and Equipment, Net	263,917	85,365
Total Assets	184,210,143	107,713,745
Accounts Payable and Accrued Expenses	11,341,789	1,671,265
Deferred Revenue	728,343	2,867,226
Builder Deposits	31,553	1,262,336
Operating Lease Liability	283,989	381,412
Note Payable	317,671	172,706
Note Payable- Related Parties	833,658	2,534,281
Total Current Liabilities	13,537,003	8,889,226
Operating Lease Liability	383,354	193,342
Notes Payable		636,362
Total Liabilities	13,920,357	9,718,930
Common Stock	87,368	8,570
Additional Paid in Capital	296,181,977	102,729,944
Accumulated Deficit	(148,233,473)	(44,910,297)
Accumulated Other Comprehensive Income	341,646	2,143,338	$ 1,458,289
Total Stockholders’ Equity	148,377,518	59,971,555
Non-controlling Interests	21,912,268	38,023,260
Total Stockholders’ Equity	170,289,786	97,994,815	$ 23,660,219
Total Liabilities and Stockholders’ Equity	184,210,143	107,713,745
As Restated [Member]
Total Revenue	16,238,200
Cost of Sales	12,085,574
General and Administrative	6,337,364
Research and Development
Total Operation Expenses	18,422,938
Loss From Continuing Operations	(2,184,738)
Interest Income	65,751
Interest Expense	(147,640)
Net Gain on Investment in Alset International during the Unconsolidated Period	61,346
Foreign Exchange Transaction Loss	(371,603)
Unrealized Gain (Loss) on Securities Investment	(1,694,535)
Realized Gain (Loss) on Securities Investment	(192,459)
Loss on Investment on Security by Equity Method	(227,643)
Finance Costs	(109,916)
Other Income	127,100
Total Other Expense, Net	(2,489,599)
Net Loss from Continuing Operations Before Income Taxes	(4,674,337)
Income Tax Expense from Continuing Operations	(8,543)
Net Loss from Continuing Operations	(4,682,880)
Loss from Discontinued Operations, Net of Tax	(417,438)
Net Loss	(5,100,318)
Net Loss Attributable to Non-Controlling Interest	(1,948,661)
Net Loss Attributable to Common Stockholders	(3,151,657)
Unrealized Gain on Securities Investment	19,486
Foreign Currency Translation Adjustment	1,148,898
Comprehensive Loss	(3,931,934)
Comprehensive Loss Attributable to Non-Controlling Interests	(1,381,863)
Comprehensive Loss Attributable to Common Stockholders	$ (2,550,071)
Continuing Operations	$ (0.33)
Discontinued Operations	(0.04)
Net Loss Per Common Share	$ (0.37)
Weighted Average Common Shares Outstanding - Basic and Diluted	8,352,425
Cash		24,965,946
Restricted Cash		6,769,533
Account Receivables, Net		1,366,194
Other Receivables		644,576
Note Receivables - Related Party		649,569
Prepaid Expenses		1,470,680
Inventory		90,068
Investment in Securities at Fair Value		49,172,457
Investment in Securities at Cost		280,516
Investment in Securities on Equity Method
Deposits		48,820
Total Current Assets		85,458,359
Properties under Development		20,505,591
Operating Lease Right-Of-Use Asset		574,754
Deposit		249,676
Loan Receivable		840,000
Property and Equipment, Net		85,365
Total Assets		107,713,745
Accounts Payable and Accrued Expenses		1,671,265
Deferred Revenue		2,867,226
Builder Deposits		1,262,336
Operating Lease Liability		381,412
Note Payable		172,706
Note Payable- Related Parties		2,534,281
Total Current Liabilities		8,889,226
Operating Lease Liability		193,342
Notes Payable		636,362
Total Liabilities		9,718,930
Common Stock		8,570
Additional Paid in Capital		102,729,944
Accumulated Deficit		(44,910,297)
Accumulated Other Comprehensive Income		2,143,338
Total Stockholders’ Equity		59,971,555
Non-controlling Interests		38,023,260
Total Stockholders’ Equity		97,994,815
Total Liabilities and Stockholders’ Equity		107,713,745
American Pacific Bancorp Inc And Heng Feng Finance Limited [Member]
Total Revenue
Cost of Sales
General and Administrative	385,735
Research and Development
Total Operation Expenses	385,735
Loss From Continuing Operations	(385,735)
Interest Income	49,356
Interest Expense
Foreign Exchange Transaction Loss
Unrealized Gain (Loss) on Securities Investment	55,788
Finance Costs	(109,916)
Other Income	2,633
Total Other Expense, Net	(2,139)
Net Loss from Continuing Operations Before Income Taxes	(387,874)
Income Tax Expense from Continuing Operations
Net Loss from Continuing Operations	(387,874)
Loss from Discontinued Operations, Net of Tax
Net Loss	(387,874)
Net Loss Attributable to Non-Controlling Interest	(67,102)
Net Loss Attributable to Common Stockholders	(320,772)
Unrealized Gain on Securities Investment
Foreign Currency Translation Adjustment
Comprehensive Loss	(387,874)
Comprehensive Loss Attributable to Non-Controlling Interests	(67,102)
Comprehensive Loss Attributable to Common Stockholders	(320,772)
Liquid Value Development Pte Ltd [Member]
Total Revenue
Cost of Sales
General and Administrative	108,562
Research and Development
Total Operation Expenses	108,562
Loss From Continuing Operations	(108,562)
Interest Income	74
Interest Expense
Foreign Exchange Transaction Loss	(17,211)
Unrealized Gain (Loss) on Securities Investment	131
Realized Gain (Loss) on Securities Investment	(193,574)
Finance Costs
Other Income	5,133
Total Other Expense, Net	(205,447)
Net Loss from Continuing Operations Before Income Taxes	(314,009)
Income Tax Expense from Continuing Operations
Net Loss from Continuing Operations	(314,009)
Loss from Discontinued Operations, Net of Tax
Net Loss	(314,009)
Net Loss Attributable to Non-Controlling Interest
Net Loss Attributable to Common Stockholders	(314,009)
Unrealized Gain on Securities Investment
Foreign Currency Translation Adjustment
Comprehensive Loss	(314,009)
Comprehensive Loss Attributable to Non-Controlling Interests
Comprehensive Loss Attributable to Common Stockholders	(314,009)
Cash		492,977
Restricted Cash
Account Receivables, Net
Other Receivables		95,177
Note Receivables - Related Party
Prepaid Expenses
Inventory
Investment in Securities at Fair Value		1,631
Investment in Securities at Cost
Investment in Securities on Equity Method		74,535
Deposits
Total Current Assets		664,320
Properties under Development
Operating Lease Right-Of-Use Asset
Deposit
Loan Receivable
Property and Equipment, Net
Total Assets		664,320
Accounts Payable and Accrued Expenses
Deferred Revenue
Builder Deposits
Operating Lease Liability
Note Payable
Note Payable- Related Parties		823,823
Total Current Liabilities		823,823
Operating Lease Liability
Notes Payable
Total Liabilities		823,823
Common Stock
Additional Paid in Capital		756,487
Accumulated Deficit		(906,010)
Accumulated Other Comprehensive Income		(9,980)
Total Stockholders’ Equity		(159,503)
Non-controlling Interests
Total Stockholders’ Equity		(159,503)
Total Liabilities and Stockholders’ Equity		664,320
American Pacific Bancorp Inc [Member]
Cash		2,348,478
Restricted Cash
Account Receivables, Net
Other Receivables		279,177
Note Receivables - Related Party		24,583
Prepaid Expenses
Inventory
Investment in Securities at Fair Value		313,343
Investment in Securities at Cost
Investment in Securities on Equity Method
Deposits		1,801
Total Current Assets		2,967,382
Properties under Development
Operating Lease Right-Of-Use Asset
Deposit
Loan Receivable		840,000
Property and Equipment, Net
Total Assets		3,807,382
Accounts Payable and Accrued Expenses		118,133
Deferred Revenue
Builder Deposits
Operating Lease Liability
Note Payable
Note Payable- Related Parties		184,250
Total Current Liabilities		302,383
Operating Lease Liability
Notes Payable
Total Liabilities		302,383
Common Stock		47,756
Additional Paid in Capital		3,975,261
Accumulated Deficit		(993,296)
Accumulated Other Comprehensive Income
Total Stockholders’ Equity		3,029,721
Non-controlling Interests		475,278
Total Stockholders’ Equity		3,504,999
Total Liabilities and Stockholders’ Equity		3,807,382
Property Sales [Member] | As Restated [Member]
Total Revenue	13,643,689
Property Sales [Member] | American Pacific Bancorp Inc And Heng Feng Finance Limited [Member]
Total Revenue
Property Sales [Member] | Liquid Value Development Pte Ltd [Member]
Total Revenue
Bio Health Product Sales [Member] | As Restated [Member]
Total Revenue	2,594,511
Bio Health Product Sales [Member] | American Pacific Bancorp Inc And Heng Feng Finance Limited [Member]
Total Revenue
Bio Health Product Sales [Member] | Liquid Value Development Pte Ltd [Member]
Total Revenue
Previously Reported [Member]
Total Revenue	16,238,200
Cost of Sales	12,085,574
General and Administrative	5,843,067
Research and Development
Total Operation Expenses	17,928,641
Loss From Continuing Operations	(1,690,441)
Interest Income	16,321
Interest Expense	(147,640)
Net Gain on Investment in Alset International during the Unconsolidated Period	61,346
Foreign Exchange Transaction Loss	(354,392)
Unrealized Gain (Loss) on Securities Investment	(1,750,454)
Realized Gain (Loss) on Securities Investment	1,115
Loss on Investment on Security by Equity Method	(227,643)
Finance Costs
Other Income	119,334
Total Other Expense, Net	(2,282,013)
Net Loss from Continuing Operations Before Income Taxes	(3,972,454)
Income Tax Expense from Continuing Operations	(8,543)
Net Loss from Continuing Operations	(3,980,997)
Loss from Discontinued Operations, Net of Tax	(417,438)
Net Loss	(4,398,435)
Net Loss Attributable to Non-Controlling Interest	(1,881,559)
Net Loss Attributable to Common Stockholders	(2,516,876)
Unrealized Gain on Securities Investment	19,486
Foreign Currency Translation Adjustment	1,148,898
Comprehensive Loss	(3,230,051)
Comprehensive Loss Attributable to Non-Controlling Interests	(1,314,761)
Comprehensive Loss Attributable to Common Stockholders	$ (1,915,290)
Continuing Operations	$ (0.27)
Discontinued Operations	(0.03)
Net Loss Per Common Share	$ (0.30)
Weighted Average Common Shares Outstanding - Basic and Diluted	8,352,425
Cash		22,124,491
Restricted Cash		6,769,533
Account Receivables, Net		1,366,194
Other Receivables		270,222
Note Receivables - Related Party		624,986
Prepaid Expenses		1,470,680
Inventory		90,068
Investment in Securities at Fair Value		48,857,483
Investment in Securities at Cost		280,516
Investment in Securities on Equity Method
Deposits		47,019
Total Current Assets		81,901,192
Properties under Development		20,505,591
Operating Lease Right-Of-Use Asset		574,754
Deposit		249,676
Loan Receivable
Property and Equipment, Net		85,365
Total Assets		103,316,578
Accounts Payable and Accrued Expenses		1,553,132
Deferred Revenue		2,867,226
Builder Deposits		1,262,336
Operating Lease Liability		381,412
Note Payable		172,706
Note Payable- Related Parties		1,526,208
Total Current Liabilities		7,763,020
Operating Lease Liability		193,342
Notes Payable		636,362
Total Liabilities		8,592,724
Common Stock		8,570
Additional Paid in Capital		97,950,440
Accumulated Deficit		(43,010,991)
Accumulated Other Comprehensive Income		2,153,318
Total Stockholders’ Equity		57,101,337
Non-controlling Interests		37,622,517
Total Stockholders’ Equity		94,723,854
Total Liabilities and Stockholders’ Equity		103,316,578
Previously Reported [Member] | Property Sales [Member]
Total Revenue	$ 13,643,689
Previously Reported [Member] | Bio Health Product Sales [Member]
Total Revenue	$ 2,594,511
Eliminations [Member]
Cash
Restricted Cash
Account Receivables, Net
Other Receivables
Note Receivables - Related Party
Prepaid Expenses
Inventory
Investment in Securities at Fair Value
Investment in Securities at Cost
Investment in Securities on Equity Method		(74,535)
Deposits
Total Current Assets		(74,535)
Properties under Development
Operating Lease Right-Of-Use Asset
Deposit
Loan Receivable
Property and Equipment, Net
Total Assets		(74,535)
Accounts Payable and Accrued Expenses
Deferred Revenue
Builder Deposits
Operating Lease Liability
Note Payable
Note Payable- Related Parties
Total Current Liabilities
Operating Lease Liability
Notes Payable
Total Liabilities
Common Stock		(47,756)
Additional Paid in Capital		47,756
Accumulated Deficit
Accumulated Other Comprehensive Income
Total Stockholders’ Equity
Non-controlling Interests		(74,535)
Total Stockholders’ Equity		(74,535)
Total Liabilities and Stockholders’ Equity		$ (74,535)